檢索結果 - Yuping Dong

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C

    A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C 由 Robert Flisiak, Mitchell L. Shiffman, Juan Arenas, Hugo Cheinquer, И. Г. Никитин, Yuping Dong, Khurram Rana, Subasree Srinivasan

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Evinacumab in Patients with Refractory Hypercholesterolemia

    Evinacumab in Patients with Refractory Hypercholesterolemia 由 Robert S. Rosenson, Lesley Burgess, Christoph Ebenbichler, Seth J. Baum, Erik S.G. Stroes, Shazia Ali, Nagwa Khilla, Robert L. Hamlin, Robert Pordy, Yuping Dong, Vladimir Son, Daniel Gaudet

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study

    Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II stud... 由 Josep M. Grinyó, Josefina Alberú, F.L.C. Contieri, Roberto Ceratti Manfro, Guillermo Mondragón, Georgy Nainan, María del Carmen Rial, Steven Steinberg, Flavio Vincenti, Yuping Dong, Dolca Thomas, Nassim Kamar

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients

    Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients 由 R M Ferguson, J.M. Grinyó, Flavio Vincenti, Dixon B. Kaufman, E. Steve Woodle, Brad A. Marder, Franco Citterio, William H. Marks, Mamta Agarwal, D. Wu, Yuping Dong, Pushkal Garg

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia

    Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia 由 Dirk Blom, Mariko Harada–Shiba, Paolo Rubba, Daniel Gaudet, John J.P. Kastelein, Min‐Ji Charng, Robert Pordy, Stephen Donahue, Shazia Ali, Yuping Dong, Nagwa Khilla, Poulabi Banerjee, Marie T. Baccara‐Dinet, Robert S. Rosenson

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study

    Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study 由 Ana Oaknin, Bhavana Pothuri, Lucy Gilbert, Renaud Sabatier, Jubilee Brown, Sharad Ghamande, Cara Mathews, David M. O’Malley, Rebecca Kristeleit, Valentina Boni, Adriano Gravina, Susana Banerjee, Rowan Miller, Joanna Pikiel, Mansoor Raza Mirza, Ninad Dewal, Grace Antony, Yuping Dong, Eleftherios Zografos, Jennifer Veneris, Anna V. Tinker

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: